<DOC>
	<DOCNO>NCT00068341</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , docetaxel carboplatin , use different way stop tumor cell divide stop grow die . Monoclonal antibody , trastuzumab , locate tumor cell either kill deliver tumor-killing substance without harm normal cell . It yet know whether docetaxel carboplatin effective without trastuzumab treat breast cancer . PURPOSE : This randomized phase II trial study well give docetaxel together carboplatin trastuzumab surgery work compare docetaxel carboplatin alone surgery treat woman locally advance breast cancer .</brief_summary>
	<brief_title>Docetaxel Carboplatin With Without Trastuzumab Before Surgery Treating Women With Locally Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Confirmed infiltrate adenocarcinoma breast Primary breast cancer &gt; 5cm , skin/chest wall involvement , N , without evidence metastasis . No prior radiation involve breast ECOG ( Electrocochleography ) performance status 02 Age 18 year 80 year Absolute Neutrophil count &gt; 1500 cell/μl , platelet count &gt; 100000 cells/μl hemoglobin &gt; 9 g/dl All liver function test &lt; upper limit normal Serum creatinine &lt; 2.0 mg/dl Normal leave ventricular ejection fraction ( LVEF ) determine MUGA ( Multiple Gated Acquisition ) scan echocardiogram HER2/neu status determine FISH ( Fluorescence situ hybridization ) test . [ FISH ( + ) HER2/neu ( + ) ] If female childbearing potential , pregnancy test negative If premenopausal surgically sterilize , patient agrees use effective birth control method duration study Informed consent obtain Nonconfirmed infiltrate adenocarcinoma breast cancer Evidence metastasis Previous chemotherapy use drug propose study , specifically Herceptin® , Taxotere® , and/or Carboplatin Prior radiation involve breast Recent breast cancer drug therapy within last 5 year form History allergy polysorbate castor oil Ongoing active infection Concurrent lifelimiting disease life expectancy le one year Past current history malignancy within past 5 year could affect diagnosis assessment breast cancer , except curatively treat nonmelanoma skin cancer and/or situ carcinoma cervix Pregnancy , nursing , fertile woman use birth control device Inability give inform consent Patients preexist peripheral neuropathy &gt; grade 2</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>